Livforsakringsbolaget Skandia Omsesidigt Grows Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Livforsakringsbolaget Skandia Omsesidigt increased its stake in Intuitive Surgical, Inc. by 14.0%, acquiring an additional 1,200 shares, bringing its total holdings to 9,743 shares valued at approximately $5.3 million.
• Intuitive Surgical reported a 21.4% year-over-year increase in quarterly revenue to $2.44 billion and earnings per share of $2.19, surpassing estimates and indicating strong financial performance.
• Institutional investors hold 83.64% of Intuitive Surgical's stock, with recent analysts maintaining a consensus rating of "Moderate Buy" and a price target averaging around $595.95.

Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,743 shares of the medical equipment provider's stock after purchasing an additional 1,200 shares during the period. Livforsakringsbolaget Skandia Omsesidigt's holdings in Intuitive Surgical were worth $5,294,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock worth $16,178,258,000 after buying an additional 453,335 shares during the period. Invesco Ltd. boosted its stake in shares of Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider's stock valued at $2,090,027,000 after buying an additional 71,794 shares during the last quarter. Northern Trust Corp grew its stake in shares of Intuitive Surgical by 0.3% in the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider's stock worth $1,798,465,000 after purchasing an additional 11,988 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $1,715,899,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

ISRG traded up $2.89 during trading on Friday, reaching $438.72. The company had a trading volume of 3,756,410 shares, compared to its average volume of 2,285,360. The company has a market cap of $157.27 billion, a price-to-earnings ratio of 61.19, a PEG ratio of 4.60 and a beta of 1.61. The firm's 50-day simple moving average is $476.64 and its 200 day simple moving average is $503.68. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.78 EPS. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Wells Fargo & Company upped their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. BTIG Research increased their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Finally, UBS Group lifted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research note on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus price target of $595.95.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.